:::
施瀚博

施瀚博 / Dr. Han-Po Shih

JobTitle： Assistant Research Fellow

CurrentJob： CMCI

E-mail： hpshih@cgu.edu.tw

Phone： 03-211-8800#5542

Education： PhD

Expertise： Autoantibodies Against Cytokines; Cancer Immunotherapy; Immunology of Vitiligo

Education and experience

Education
2016-2022 PhD Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University

Experience
2024 Present Assistant Researcher, Molecular and Clinical Immunology Center, Chang Gung University
2023-2024 Postdoctoral Researcher, Molecular and Clinical Immunology Center, Chang Gung University

Awards and honors

2024 Taipei Biotechnology Award for Technology Transfer Collaboration
2023 Shen Shui-De Academic Paper Award
2021 Scholarship, Séjour scientifique de haut niveau (SSHN), Institut Pasteur, Paris, France
2021 Poster Award, 2021 Joint Annual Conference of Taiwan Allergy and Immunology, Kaohsiung, Taiwan
2020 FISS Travel Award, The 2020 Annual Meeting of Chinese Society of Immunology, Taipei, Taiwan
2020 Fellowship, The 9th Singapore Immunology Network/Immunology Frontier Research Center (NIF) Winter School on Advanced Immunology, Osaka, Japan
2019 Award for Excellent Contributions in Technology Transfer, Ministry of Science and Technology, Taipei, Taiwan
2019 Poster Award, 2019 Formosa Immunology Spring School & Symposium (FISS), Taoyuan, Taiwan
2018 Oral Award, The 9th Annual Symposium of Graduate Institute of Clinical Medicine in Taiwan Precision Medicine 2018, Taoyuan, Taiwan
2017 Scholar Exchange Program (Program Orchid), Institut Pasteur, Paris, France

Research direction

Cancer Immunotherapy; Development of therapeutic γδT cells with potent anti-tumor activity

Selected research

  • Ng CY, Chan YP, Chiu YC, Shih HP, Lin YN, Chung PH, Huang JY, Chen HK, Chung WH, Ku CL. Targeting the elevated IFN-γ in vitiligo patients by human anti-IFN-γ monoclonal antibody hampers direct cytotoxicity in melanocyte. J Dermatol Sci. 110(3):78-88. 2023.
  • Wang SY, Lo YF, Shih HP, Ho MW, Yeh CF, Peng JJ, Ting HT, Lin KH, Huang WC, Chen YC, Chiu YH, Hsu CW, Tseng YT, Wang LS, Lei WY, Lin Cy, Aoh Y, Chou CH, Wu TY, Ding JY, Lo CC, Lin YN, Tu KH, Lei WT, Kuo CY, Chi CY, Ku CL. Cryptococcus gatti Infection as the Major Clinical Manifestation in Patients with Autoantibodies Against Granulocyte-Macrophage Colony-Stimulating Factor. J Clin Immunol. 42(8):1730-1741. 2022.
  • Shih HP, Ding JY, Bellón JS, Lo YF, Chung PH, Ting HT, Peng JJ, Wu TY, Lin CH, Lo CC, Lin YN, Yeh CF, Chen JB, Wu TS, Liu YM, Kuo CY, Wang SY, Tu KH, Ng CY, Lei WT, Tsai YH, Chen JH, Chang YT, Huang JY, Rey FA, Chen HK, Chang TW, Piehler J, Chi CY, Ku CL. Pathogenic autoantibodies to IFN-γ act through the impedance of receptor assembly and Fc-mediated response. J Exp Med. 219(9):e20212126. 2022.
  • Shih HP, Ding JY, Yeh CF, Chi CY, Ku CL. Anti-interferon-γ autoantibody-associated immunodeficiency. Curr Opin Immunol. 72:206-214. 2021.